Education
About Us
Working with TipRanks
Follow Us
Livzon Pharmaceutical Group Class H (HK:1513)
:1513
Earnings Data
Report Date
Mar 26, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.46Last Year’s EPS
0.47Same Quarter Last Year
Moderate Sell
Based on 1 Analysts Ratings
HK:1513 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:1513 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 23, 2025 | HK$32.58 | HK$31.84 | -2.27% |
Aug 20, 2025 | HK$37.08 | HK$36.64 | -1.19% |
Apr 23, 2025 | HK$25.63 | HK$25.82 | +0.75% |
Mar 26, 2025 | HK$25.39 | HK$25.29 | -0.38% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Livzon Pharmaceutical Group Class H (HK:1513) report earnings?
Livzon Pharmaceutical Group Class H (HK:1513) is schdueled to report earning on Mar 26, 2026, TBA (Confirmed).
What is Livzon Pharmaceutical Group Class H (HK:1513) earnings time?
Livzon Pharmaceutical Group Class H (HK:1513) earnings time is at Mar 26, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Livzon Pharmaceutical Group Class H stock?
The P/E ratio of Livzon Pharmaceutical Group is N/A.
What is HK:1513 EPS forecast?
HK:1513 EPS forecast for the fiscal quarter 2025 (Q4) is 0.46.